Literature DB >> 14510617

The synthesis of SO-3, a conopeptide with high analgesic activity derived from Conus striatus.

Qiuyun Dai1, Fengyun Liu, Yanrong Zhou, Baisong Lu, Fang Yu, Peitang Huang.   

Abstract

The synthesis and characterization of the conopeptide, SO-3, originally derived from Conus striatus is reported. It contains 25 amino acid residues and three disulfide bridges and manifests 72% sequence identity with MVIIA, an N-type Ca2+ channel inhibitor of high analgesic activity. We evaluated SO-3 in several mouse models of pain. The results indicate that SO-3 is a potent, nonaddictive, analgesic agent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510617     DOI: 10.1021/np030099y

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  6 in total

1.  SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons.

Authors:  Lei Wen; Sheng Yang; Haifa Qiao; Zhenwei Liu; Wenxia Zhou; Yongxiang Zhang; Peitang Huang
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 2.  Biologic poisons for pain.

Authors:  Lori Reisner
Journal:  Curr Pain Headache Rep       Date:  2004-12

3.  Analgesic effect of highly reversible ω-conotoxin FVIA on N type Ca2+ channels.

Authors:  Seungkyu Lee; Yoonji Kim; Seung Keun Back; Hee-Woo Choi; Ju Yeon Lee; Hyun Ho Jung; Jae Ha Ryu; Hong-Won Suh; Heung Sik Na; Hyun Jeong Kim; Hyewhon Rhim; Jae Il Kim
Journal:  Mol Pain       Date:  2010-12-21       Impact factor: 3.395

4.  Bioactive marine drugs and marine biomaterials for brain diseases.

Authors:  Clara Grosso; Patrícia Valentão; Federico Ferreres; Paula B Andrade
Journal:  Mar Drugs       Date:  2014-05-02       Impact factor: 5.118

5.  DSPE-PEG Modification of α-Conotoxin TxID.

Authors:  Weinan Zhao; Yang Xiong; Dongting Zhangsun; Sulan Luo
Journal:  Mar Drugs       Date:  2019-06-08       Impact factor: 5.118

6.  A novel α-conopeptide Eu1.6 inhibits N-type (CaV2.2) calcium channels and exhibits potent analgesic activity.

Authors:  Zhuguo Liu; Peter Bartels; Mahsa Sadeghi; Tianpeng Du; Qing Dai; Cui Zhu; Shuo Yu; Shuo Wang; Mingxin Dong; Ting Sun; Jiabin Guo; Shuangqing Peng; Ling Jiang; David J Adams; Qiuyun Dai
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.